IP Library › Granted Patent US 11,739,442
Granted Patent B2
US 11,739,442 · App. 17/406,954 · Granted Aug 29, 2023

TCR libraries

Inventors: Bent Karsten Jakobsen (Abingdon, GB); Nathaniel Ross Liddy (Abingdon, GB); Peter Eamon Molloy (Abingdon, GB); Annelise Brigitte Vuidepot (Abingdon, GB)
Assignees: Immunocore Limited; Adaptimune Limited
C40B30/04C07K14/7051C12N15/1037C40B40/02C40B40/10C07K2317/565
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,739,442
App. No.
17/406,954
Granted
Aug 29, 2023
Kind
B2
Abstract

The present invention relates to a library of particles, the library displaying a plurality of different T cell receptors (TCRs), wherein the plurality of TCRs consists essentially of TCRs comprising an alpha chain variable domain and a beta chain variable domain, wherein the alpha chain variable domain comprises a TRAV12-2 gene product and the beta chain variable domain comprises a TRBV gene product.

Claims (73)

1. A method of obtaining a T cell receptor that specifically binds a peptide antigen, comprising screening a library of particles displaying a plurality of different T cell receptors (TCRs) with the peptide antigen, wherein the plurality of TCRS consists essentially of TCRs comprising (a) an alpha chain variable domain (Vα) that is a TRAV12-2 gene product from a natural repertoire of TCRs, and (b) a beta chain, the beta chain comprising a beta chain variable domain (Vβ) that is a gene product of a TRBV gene, wherein the Vα CDR3 length varies among the plurality of displayed TCRs and the Vβ CDR3 length varies among the plurality of displayed TCR, wherein the TCRs are covalently linked to the particles, and wherein the particles are phage particles, ribosomes, yeast cells, or mammalian cells, the method comprising:

(1) panning the library using as a target the peptide antigen;

(2) repeating step (1) one or more times;

(3) screening the phage clones identified in step (1) or (2); and

(4) identifying a TCR that specifically binds the peptide antigen.

2. The method of claim 1 , wherein the single TRBV gene is one of:

TRBV1

TRBV2

TRBV3-1

TRBV3-2

TRBV4-1

TRBV4-2

TRBV4-3

TRBV5-1

TRBV5-2

TRBV5-3

TRBV5-4

TRBV5-5

TRBV5-6

TRBV5-7

TRBV5-8

TRBV6-1

TRBV6-2

TRBV6-3

TRBV6-4

TRBV6-5

TRBV6-6

TRBV6-7

TRBV6-8

TRBV6-9

TRBV7-1

TRBV7-2

TRBV7-3

TRBV7-4

TRBV7-5

TRBV7-6

TRBV7-7

TRBV7-8

TRBV7-9

TRBV8-1

TRBV8-2

TRBV9

TRBV10-1

TRBV10-2

TRBV10-3

TRBV11-1

TRBV11-2

TRBV11-3

TRBV12-1

TRBV12-2

TRBV12-3

TRBV12-4

TRBV12-5

TRBV13

TRBV14

TRBV15

TRBV16

TRBV17

TRBV18

TRBV19

TRBV20-1

TRBV21-1

TRBV22-1

TRBV23-1

TRBV24-1

TRBV25-1

TRBV26

TRBV27

TRBV28

TRBV29-1

TRBV30

3. The method of claim 1 , wherein the alpha chain variable domain and the beta chain variable domain are displayed as a single chain polypeptide.

4. The method of claim 1 , wherein the peptide antigen comprises HLA-A2.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2026
From: ADAPTIMMUNE LIMITED
To: IMMUNOCORE LIMITED
Reel/Frame 075813/0266 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE CONVEYING PARTY NAME ON THE COVER SHEET FROM "IMMUNOCRE LIMITED" TO --IMMUNOCORE LIMITED-- PREVIOUSLY RECORDED AT REEL: 582881 FRAME: 943. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 12, 2025
From: IMMUNOCORE LIMITED
To: IMMUNOCORE LIMITED; ADAPTIMMUNE THERAPEUTICS PLC
Reel/Frame 070486/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2021
From: JAKOBSEN, BENT KARSTEN; LIDDY, NATHANIEL ROSS; MOLLOY, PETER EAMON; VUIDEPOT, ANNELISE BRIGITTE
To: IMMUNOCORE LIMITED
Reel/Frame 058282/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2021
From: IMMUNOCRE LIMITED
To: IMMUNOCORE LIMITED; ADAPTIMMUNE THERAPEUTICS PLC
Reel/Frame 058281/0943 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2021
From: ADAPTIMMUNE THERAPEUTICS PLC
To: ADAPTIMMUNE LIMITED
Reel/Frame 058281/0966 →
Priority Claims (1)
GB 1516272 · Sep 15, 2015 · national
Continuity (2)
Continuation 15759775
Related Publication 20210395332A1 · Dec 23, 2021